E
InMed Pharmaceuticals Inc. INM
$0.88 -$0.01-1.47% NASDAQ
Recommendation
Dividend Power Score
Prev Close
$0.89
Volume
52,021
Avg Vol (90D)
274,328
Market Cap
$3.62M
Dividend & Yield
--
52-Week Range
$0.89 - $7.98
P/E (TTM)
--
EPS (TTM)
-$4.29
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
2/11/2026 - Newsfile Corp. - News Releases
InMed Shareholders Approve Directors and Equity Financing Flexibility
12/18/2025 - TipRanks Financial Blog
InMed Pharmaceuticals Inc. (INM) Shareholder/Analyst Call Prepared Remarks Transcript
12/18/2025 - Seeking Alpha: Transcripts
InMed Pharmaceuticals Inc. (INM) Shareholder/Analyst Call Prepared Remarks Transcript
12/18/2025 - SeekingAlpha
InMed Announces Results of 2025 Annual General and Special Meeting
12/18/2025 - Newsfile Corp. - News Releases
InMed Provides Update on BayMedica Commercial Business
12/12/2025 - Newsfile Corp. - News Releases
Life Sciences Virtual Investor Forum Agenda Announced for December 11th
12/9/2025 - Globe Newswire
InMed Pharmaceuticals (INM) Achieves Milestone with INM-901 Study Success
11/18/2025 - GuruFocus
InMed Completes Key Pharmacokinetic Studies for Alzheimer's Candidate INM-901
11/18/2025 - TipRanks Financial Blog
InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901
11/18/2025 - Newsfile Corp. - News Releases
InMed Pharmaceuticals (NASDAQ:INM) Issues Earnings Results
11/8/2025 - Ticker Report
InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update
11/6/2025 - Newsfile Corp. - News Releases
Inmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors
10/16/2025 - Newsfile Corp. - News Releases
InMed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors
10/16/2025 - Newsfile Corp. - News Releases
Head-To-Head Comparison: InMed Pharmaceuticals (NASDAQ:INM) vs. CytoDyn (OTCMKTS:CYDY)
10/12/2025 - Ticker Report
InMed Pharmaceuticals Appoints Mr. Neil Klompas to It's Board of Directors
10/9/2025 - Newsfile Corp. - News Releases
InMed Pharmaceuticals reports FY25 EPS ($8.36) vs ($20.14) last year
9/23/2025 - The Fly
InMed Pharmaceuticals GAAP EPS of -$8.36, revenue of $4.94M
9/23/2025 - SeekingAlpha.com: All News
InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update
9/23/2025 - Newsfile Corp. - News Releases
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
9/18/2025 - Globe Newswire
InMed to Present at the Life Sciences Virtual Investor Forum September 18th, 2025
9/16/2025 - Globe Newswire
Life Science Virtual Investor Forum Agenda Announced for September 18th
9/16/2025 - Globe Newswire
InMed Pharmaceuticals to Showcase Pipeline Progress at Global Investment Conference
9/5/2025 - TipRanks Financial Blog
InMed to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
9/5/2025 - Newsfile Corp. - News Releases
Income Statement
Total Revenue (TTM)
$4.51M
EBITDA (TTM)
-$7.63M
EBIT (TTM)
-$7.84M
Net Income (TTM)
-$7.66M
Balance Sheet
Total Assets (Q)
$11.19M
Total Debt (Q)
$531.90K
Total Liabilities (Q)
$1.60M
Book Value Per Share (Q)
$3.42
Cash Flow
Cash from Operations (TTM)
-$7.42M
Cash from Investing (TTM)
$0.00
Cash from Financing (TTM)
$10.96M
Net Change in Cash (TTM)
$3.54M
Filings
Filing Date
Wednesday, February 11, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Loading...
Beta
3.00
7-Day Total Return
-12.30%
30-Day Total Return
-17.26%
60-Day Total Return
-46.85%
90-Day Total Return
-60.85%
Year to Date Total Return
-21.70%
1-Year Total Return
-71.71%
2-Year Total Return
-87.68%
3-Year Total Return
-97.58%
5-Year Total Return
-99.97%
52-week Low
Feb 12, 2026 - $0.89
52-week High
Jun 02, 2025 - $7.98
Valuation
Market Cap
$3.62M - Nano Cap
Enterprise Value
-$2.84M
Price/Sales (TTM)
0.55
Price/Book (Q)
0.26
Dividends and Shares
Shares Outstanding
2.80M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.inmedpharma.com
Phone Number
604 669 7207
Address
885 West Georgia Street
Vancouver, BC V6C 3E8
Country
Canada
Year Founded
1981
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. The company operates through two segments, InMed... more
NASDAQ 02/13/2026 4:00PM Eastern Quotes delayed